T Cell Regulation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14105293

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Regulatory T cells (Treg) limit autoimmunity but can also attenuate the magnitude of anti-pathogen and anti-tumor immunity. Understanding the mechanism of Treg function and therapeutic manipulation of Treg in vivo requires identification of Treg selective receptors. A comparative analysis of gene expression arrays from antigen specific CD4+ T cells differentiating to either an effector/memory or a regulatory phenotype revealed Treg selective expression of LAG-3 (CD223), a CD4-related molecule that binds MHC class II. LAG-3 expression on CD4+ T cells correlates with the cells' in vitro suppressor activity, and ectopic expression of LAG-3 on CD4 T cells confers suppressor activity on the T cells. Antibodies to LAG-3 inhibit suppression both in vitro and in vivo. LAG-3 marks regulatory T cell populations and contributes to their suppressor activity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ST JUDE'S CHILDREN'S RESEARCH HOSPITAL INCMEMPHIS TN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
DRAKE, Charles Baltimore, US 10 152
HUANG, Ching-Tai Taipei, TW 10 150
PARDOLL, Drew M Brookeville, US 68 1050
POWELL, Jonathan Baltimore, US 26 195
VIGNALI, Dario A Germantown, US 8 149
WORKMAN, Creg J Memphis, US 8 126

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation